A Jamaican-born doctor who worried his patients could not afford their medicine built Indies Pharma from a single generic drug in 2005 into the first pharmaceutical company ever listed on the Jamaica Stock Exchange — and the first Caribbean firm to win US Food and Drug Administration approval for its own generic drug. Full nameIndies Pharma Jamaica Limited Ticker / ExchangeINDIES — Jamaica Stock Exchange (Junior Market) HeadquartersFreeport, Montego Bay, St. James, Jamaica SectorPharmaceuticals — distribution, retail & drug development Employees~65 Market value (market cap)JMD 4.49 bn (US$28.7 m) Yearly …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →